{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:02:23Z","timestamp":1789851743779,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.urolonc.2026.08.004","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:41:55Z","timestamp":1789443715000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CDKL1 facilitates tumorigenesis and metastasis of bladder urothelial carcinoma by activating SIRT1\/Wnt\/\u03b2-catenin signaling"],"prefix":"10.1016","author":[{"given":"Huajun","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfei","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmeng","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9723-8830","authenticated-orcid":false,"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.urolonc.2026.08.004_bib0001","first-page":"391","article-title":"Urothelial carcinoma: recurrence and risk factors","volume":"20","author":"Milojevic","year":"2015","journal-title":"J Buon"},{"issue":"1","key":"10.1016\/j.urolonc.2026.08.004_bib0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medsci8010015","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Med Sci (Basel)"},{"issue":"7","key":"10.1016\/j.urolonc.2026.08.004_bib0003","article-title":"A review of the etiology and epidemiology of bladder cancer: all you need to know","volume":"14","author":"Halaseh","year":"2022","journal-title":"Cureus"},{"issue":"19","key":"10.1016\/j.urolonc.2026.08.004_bib0004","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.3390\/cancers15194886","article-title":"Current and emerging strategies to treat urothelial carcinoma","volume":"15","author":"Rani","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.urolonc.2026.08.004_bib0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41585-020-0304-1","article-title":"Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes","volume":"17","author":"Meeks","year":"2020","journal-title":"Nat Rev Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.08.004_bib0006","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.celrep.2017.12.083","article-title":"CDKL family kinases have evolved distinct structural features and ciliary function","volume":"22","author":"Canning","year":"2018","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.urolonc.2026.08.004_bib0007","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/j.1460-2075.1992.tb05360.x","article-title":"A family of human cdc2-related protein kinases","volume":"11","author":"Meyerson","year":"1992","journal-title":"EMBO J"},{"issue":"6","key":"10.1016\/j.urolonc.2026.08.004_bib0008","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1046\/j.1471-4159.1995.65062577.x","article-title":"The distribution and biochemical properties of a Cdc2-related kinase, KKIALRE, in normal and Alzheimer brains","volume":"65","author":"Yen","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.urolonc.2026.08.004_bib0009","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2147\/OTT.S133014","article-title":"CDKL1 promotes tumor proliferation and invasion in colorectal cancer","volume":"10","author":"Qin","year":"2017","journal-title":"Onco Targets Ther"},{"issue":"3\u20134","key":"10.1016\/j.urolonc.2026.08.004_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41417-020-00209-0","article-title":"circRACGAP1 promotes non-small cell lung cancer proliferation by regulating miR-144-5p\/CDKL1 signaling pathway","volume":"28","author":"Lu","year":"2021","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.urolonc.2026.08.004_bib0011","doi-asserted-by":"crossref","first-page":"101995","DOI":"10.1016\/j.mcp.2024.101995","article-title":"LncRNA PVT1 promotes malignant progression by regulating the miR-7-5p\/CDKL1 axis in oral squamous cell carcinoma","volume":"78","author":"Li","year":"2024","journal-title":"Mol Cell Probes"},{"issue":"1","key":"10.1016\/j.urolonc.2026.08.004_bib0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.urolonc.2026.08.004_bib0013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev Cell"},{"issue":"1","key":"10.1016\/j.urolonc.2026.08.004_bib0014","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/dvdy.22019","article-title":"Regulation of Wnt\/beta-catenin signaling by protein kinases","volume":"239","author":"Verheyen","year":"2010","journal-title":"Dev Dyn"},{"issue":"6","key":"10.1016\/j.urolonc.2026.08.004_bib0015","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.urolonc.2026.08.004_bib0016","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2026.08.004_bib0017","doi-asserted-by":"crossref","first-page":"121270","DOI":"10.1016\/j.lfs.2022.121270","article-title":"PXDNL activates the motility of urothelial bladder carcinoma cells through the wnt\/\u03b2-catenin pathway and has a prognostic value","volume":"312","author":"Lu","year":"2023","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.urolonc.2026.08.004_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0000000000000485","article-title":"MiRNA-139-3p inhibits malignant progression in urothelial carcinoma of the bladder via targeting KIF18B and inactivating Wnt\/beta-catenin pathway","volume":"33","author":"Zhang","year":"2023","journal-title":"Pharmacogenet Genomics"},{"issue":"16","key":"10.1016\/j.urolonc.2026.08.004_bib0019","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.7150\/jca.31166","article-title":"The role of Wnt signaling pathway in tumor metabolic reprogramming","volume":"10","author":"Mo","year":"2019","journal-title":"J Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2026.08.004_bib0020","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.molcel.2012.11.022","article-title":"Glucose-induced \u03b2-catenin acetylation enhances Wnt signaling in cancer","volume":"49","author":"Chocarro-Calvo","year":"2013","journal-title":"Mol Cell"},{"issue":"14","key":"10.1016\/j.urolonc.2026.08.004_bib0021","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.7150\/ijbs.95875","article-title":"SIRT1 Mediates the antagonism of Wnt\/\u03b2-catenin pathway by vitamin D in colon carcinoma cells","volume":"20","author":"Garc\u00eda-Mart\u00ednez","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.urolonc.2026.08.004_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.07.021","article-title":"Deacetylation of \u03b2-catenin by SIRT1 regulates self-renewal and oncogenesis of liver cancer stem cells","volume":"463","author":"Chen","year":"2019","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.urolonc.2026.08.004_bib0023","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13046-021-02239-4","article-title":"FOXQ1-mediated SIRT1 upregulation enhances stemness and radio-resistance of colorectal cancer cells and restores intestinal microbiota function by promoting \u03b2-catenin nuclear translocation","volume":"41","author":"Yang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.urolonc.2026.08.004_bib0024","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3109\/0284186X.2012.665611","article-title":"A role for Cdkl1 in the development of gastric cancer","volume":"51","author":"Sun","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.urolonc.2026.08.004_bib0026","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mcp.2019.02.004","article-title":"CDKL1 promotes the chemoresistance of human oral squamous cell carcinoma cells to hydroxycamptothecin","volume":"44","author":"Li","year":"2019","journal-title":"Mol Cell Probes"},{"issue":"1","key":"10.1016\/j.urolonc.2026.08.004_bib0027","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdermsci.2015.03.020","article-title":"RNAi-mediated downregulation of CDKL1 inhibits growth and colony-formation ability, promotes apoptosis of human melanoma cells","volume":"79","author":"Song","year":"2015","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.urolonc.2026.08.004_bib0028","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12943-024-02043-6","article-title":"Insights into the structural and functional activities of forgotten kinases: PCTAIREs CDKs","volume":"23","author":"Karimbayli","year":"2024","journal-title":"Mol Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2026.08.004_bib0029","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/jcmm.13986","article-title":"LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2\/miR-298\/CDK9 axis","volume":"23","author":"Rui","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.urolonc.2026.08.004_bib0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.abb.2009.09.001","article-title":"Cordycepin causes p21WAF1-mediated G2\/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells","volume":"490","author":"Lee","year":"2009","journal-title":"Arch Biochem Biophys"},{"issue":"10","key":"10.1016\/j.urolonc.2026.08.004_bib0031","doi-asserted-by":"crossref","first-page":"9935","DOI":"10.1007\/s13277-014-1893-1","article-title":"SOX10 is a novel oncogene in hepatocellular carcinoma through wnt\/\u03b2-catenin\/TCF4 cascade","volume":"35","author":"Zhou","year":"2014","journal-title":"Tumour Biol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.08.004_bib0032","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.juro.2015.07.032","article-title":"Genetic variants in the wnt\/\u03b2-catenin signaling pathway as indicators of bladder cancer risk","volume":"194","author":"Pierzynski","year":"2015","journal-title":"J Urol"},{"issue":"13","key":"10.1016\/j.urolonc.2026.08.004_bib0033","doi-asserted-by":"crossref","first-page":"11060","DOI":"10.18632\/oncotarget.24308","article-title":"Three-dimensional organoid culture reveals involvement of wnt\/\u03b2-catenin pathway in proliferation of bladder cancer cells","volume":"9","author":"Yoshida","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.urolonc.2026.08.004_bib0034","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/1078-0432.CCR-05-1344","article-title":"Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt\/beta-catenin signaling pathway","volume":"12","author":"Urakami","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.urolonc.2026.08.004_bib0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.08.004_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005246","article-title":"Cooperative action of Cdk1\/cyclin B and SIRT1 is required for mitotic repression of rRNA synthesis","volume":"11","author":"Voit","year":"2015","journal-title":"PLoS Genet"},{"issue":"3","key":"10.1016\/j.urolonc.2026.08.004_bib0037","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/ars.2020.8038","article-title":"Cdk5-Mediated phosphorylation of Sirt1 contributes to podocyte mitochondrial dysfunction in diabetic nephropathy","volume":"34","author":"Wang","year":"2021","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"10.1016\/j.urolonc.2026.08.004_bib0038","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1080\/15548627.2021.2007027","article-title":"CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma","volume":"18","author":"Yao","year":"2022","journal-title":"Autophagy"},{"issue":"12","key":"10.1016\/j.urolonc.2026.08.004_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004020","article-title":"Phosphorylation regulates SIRT1 function","volume":"3","author":"Sasaki","year":"2008","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.urolonc.2026.08.004_bib0040","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/1878-0261.13143","article-title":"JNK-mediated Ser27 phosphorylation and stabilization of SIRT1 promote growth and progression of colon cancer through deacetylation-dependent activation of Snail","volume":"16","author":"Lee","year":"2022","journal-title":"Mol Oncol"},{"issue":"28","key":"10.1016\/j.urolonc.2026.08.004_bib0041","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1074\/jbc.RA117.001387","article-title":"JAK1-mediated Sirt1 phosphorylation functions as a negative feedback of the JAK1-STAT3 pathway","volume":"293","author":"Wang","year":"2018","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.urolonc.2026.08.004_bib0042","first-page":"2923","article-title":"Protein acetylation and deacetylation: an important regulatory modification in gene transcription (Review)","volume":"20","author":"Xia","year":"2020","journal-title":"Exp Ther Med"},{"issue":"8","key":"10.1016\/j.urolonc.2026.08.004_bib0043","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1128\/MCB.24.8.3404-3414.2004","article-title":"Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction","volume":"24","author":"L\u00e9vy","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"28","key":"10.1016\/j.urolonc.2026.08.004_bib0044","doi-asserted-by":"crossref","first-page":"25562","DOI":"10.1074\/jbc.M201196200","article-title":"Acetylation of beta-catenin by CREB-binding protein (CBP)","volume":"277","author":"Wolf","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.urolonc.2026.08.004_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s11658-021-00305-5","article-title":"The interaction of canonical Wnt\/\u03b2-catenin signaling with protein lysine acetylation","volume":"27","author":"You","year":"2022","journal-title":"Cell Mol Biol Lett"},{"issue":"3","key":"10.1016\/j.urolonc.2026.08.004_bib0046","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/emmm.201201606","article-title":"SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating \u03b2-catenin","volume":"5","author":"Simic","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"4","key":"10.1016\/j.urolonc.2026.08.004_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002020","article-title":"The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth","volume":"3","author":"Firestein","year":"2008","journal-title":"PLoS One"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:06:53Z","timestamp":1789848413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926006940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"alternative-id":["S1078143926006940"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.08.004","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CDKL1 facilitates tumorigenesis and metastasis of bladder urothelial carcinoma by activating SIRT1\/Wnt\/\u03b2-catenin signaling","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}